Top

Supportive Care in Cancer

Published in:

Open Access 01-09-2018 | Original Article

Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China

Authors: Yanbo Wang, Suyun Fan, Hongbiao Wang, Li Li, Yanyan Jia, Li Chai

Published in: Supportive Care in Cancer | Issue 9/2018

Abstract

Purpose

Thyroid cancer, especially differentiated thyroid cancer (DTC), is a highly prevalent chronic disease that is known to cause considerable distress, related both to the high recurrence and treatment of the disease. The Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2) has been developed as a visual measure to assess suffering. The aim of this study was to evaluate the ability of the instrument to identify patients with DTC with different levels of suffering who may need additional support care.

Methods

Participants were 338 adult inpatients with DTC who were accepting the radioiodine for remnant ablation in the nuclear medicine department. The assessment tools included the following: (1) the PRISM-R2, yielding Self-Illness Separation (SIS) and Illness Perception Measure (IPM); (2) distress thermometer (DT), a measure of thyroid cancer-related distress; (3) posttraumatic growth inventory (PTGI); (4) 12-item Short-Form health survey (SF-12); and (5) the Supportive Care Needs Survey Short Form (SCNS-SF34). In addition, the content validity of PRISM-R2 was tested using the patients’ comments.

Results

SIS and IPM showed medium intercorrelation (r = −.482; p < 0.01), and both of them showed strongly significant associations with DT. SIS also showed significant correlations with one factor of PTGI (personal strength), four factors of SF-12 (general health, role-emotional, mental health, and vitality), and one factor of SCNS-SF34 (psychological needs). IPM showed significant correlations with five factors of SF-12 and all the factors of SCNS-SF34. No correlation was found between IPM and PTGI.

Conclusions

PRISM-R2 is a well-accepted and understandable tool to assess the psychological burden of patients with thyroid cancer in Chinese settings. It may be useful to guide or evaluate the interventions for the patients.

Cooper DS, Dohety GM, Haugen BR (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 20(8):942–942

Taieb D, Baumstarck-Barrauk K, Sebag F (2011) Heath-related quality of life in thyroid cancer patients following radioiodine ablation. Health Qual Life Out 9:33CrossRef

Massolt ET, Vander WM, Korevaar TM, Kam BLR, Burger JW (2016) Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer. Clin Endocrinol 85(5):781–788CrossRef

Applewhite MK, James BC, Kaplan SP, Angelos P, Kaplan EL, Grogan RH, Aschebrook-Kilfoy B (2016) Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg 40(3):551–561CrossRefPubMed

Banach R, Bartès B, Farnell K, Rimmele H, Shey J, Singer S, Verburg FA, Luster M (2013) Results of the thyroid cancer alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. HORMONES 12(3):428–438PubMedCrossRef

Roerink SH, de Ridder M, Prins J, Huijbers A, de Wilt HJ et al (2013) High level of distress in long-term survivors of thyroid carcinoma: results of rapid screening using the distress thermometer. Acta Oncol 52(1):128–137CrossRefPubMed

Hirsch D, Ginat M, Levy S, Benbassat C, Weinstein R, Tsvetov G, Singer J, Shraga-Slutzky I, Grozinski-Glasberg S, Mansiterski Y, Shimon I, Reicher-Atir R (2009) Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid 19(5):459–465CrossRefPubMed

Cassell E (1991) The nature of suffering. In: The nature of suffering and the goals in medicine edited by: Cassell EJ. Oxford University Press, New York, pp 31–47

Cassell E (1999) Diagnosing suffering: a perspective. Ann Intern Med 131(7):531–534CrossRefPubMed

10.

Lehmann V, Oerlemans S, van de Poll-Franse LV (2011) Suffering in long-term cancer survivors: an evaluation of the PRISM-R2 in a population-based cohort. Qual Life Res 20(10):1645–1654CrossRefPubMedPubMedCentral

11.

Büchi S, Sensky T, Sharpe L (1998) Graphic representation of illness: a novel method of measuring patients’ perception of the impact of illness. Psychother Psychosom 67:222–225CrossRefPubMed

12.

Büchi S, Buddeberg C, Klaghofer R (2002) Preliminary validation of PRISM (Pictorial Representation of Illness and Self Measure)—a brief method to assess suffering. Psychother Psychosom 71(6):333–341CrossRefPubMed

13.

Lima-Verde AC, Pozza DH, Rodrigues LL (2013) Cross-cultural adaptation and validation for Portuguese (Brazilian) of the Pictorial Representation of Illness and Self Measure instrument in orofacial pain patients. J Orofac Pain 27(3):271–275PubMed

14.

Krikorian A, Limonero JT, Vargas JJ, Palacio C (2013) Assessing suffering in advanced cancer patients using Pictorial Representation of Illness and Self-Measure (PRISM), preliminary validation of the Spanish version in a Latin American population. Support Care Cancer 21(12):3327–3336CrossRefPubMed

15.

Wouters EJ, Reimus JL, van Nunen AM, Blokhorst MG, Vingerhoets AJ (2008) Suffering quantified? Feasibility and psychometric characteristics of 2 revised versions of the Pictorial Representation of Illness and Self Measure (PRISM). Behav Med 34(2):65–78CrossRefPubMed

16.

Liu Y, Zhang S, Chen W (2012) Trend of incidence and mortality on thyroid cancer in China during 2003-2007. Chin. J Epidemiol 33(10):1044–1048

17.

Husson O, Haak HR, Oranje WA, Mols F, Reems PH (2011) Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol 75(4):544–554CrossRef

18.

Pincus T, Morley S (2001) Cognitive-processing bias in chronic pain: a review and integration. Psychol Bull 127(5):599–617CrossRefPubMed

19.

Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, Jone L (2008) Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psycho-Oncol 17:538–547CrossRef

20.

Zhang N, Zhang W, Song L (2010) Application of the NCCN distress thermometer in Chinese cancer patients. Chin Ment Health J 24(12):897–901

21.

Shou J, Ren L, Wang H, Yan F, Cao X, Wang H, Wang Z, Zhu S, Liu Y (2016) Reliability and validity of 12-item Short-Form health survey (SF-12) for the health status of Chinese community elderly population in Xujiahui district of Shanghai. Aging Clin Exp Res 28(2):339–346CrossRefPubMed

22.

Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients' perceived needs: development and validation of the 34-item supportive care needs survey (SCNS-SF34). J Eval Clin Pract 15(4):602–606CrossRefPubMed

23.

Au A, Lam WWT, Kwong A, Suen D, Tsang J, Yeo W, Suen J, Ho WM, Yau TK, Soong I, Wong KY, Sze WK, Ng A, Girgis A, Fielding R (2011) Validation of the Chinese version of the Short-Form Supportive Care Needs Survey Questionnaire (SCNS-SF34-C). Psycho-Oncol 20(12):1292–1300CrossRef

24.

Calhoun LG, Tedeschi RG (1996) The posttraumatic growth inventory: measuring the positive legacy of trauma. J Trama Stress 9(3):455–471CrossRef

25.

Wang YB, HB W, Liu XH (2013) Prevalence and predictors of posttraumatic growth in accidentally injured patients. J Clin Psychol Med Settings 20(1):3–12CrossRefPubMed

26.

Elo S, Kyngäs H (2008) The qualitative content analysis process. J Adv Nur 62(1):107–115CrossRef

27.

Cohen J (1988) Statistical power analysis for the behavioral sciences. Psychology Press, New Jersey

28.

Fotiou K, Hofmann M, Fotiou K, Kaufmann R, Thaci D (2015) Pictorial Representation of Illness and Self Measure (PRISM): an effective tool to assess the burden of psoriasis. J Eur Acad Dermatol Venereol 29(12):2356–2362CrossRefPubMed

29.

Kassardjian CD, Gardner-Nix J, Dupak K, Barbati J, Lam-McCullock J (2008) Validating PRISM (Pictorial Representation of Illness and Self Measure) as a measure of suffering in chronic non-cancer pain patients. J Pain 9(12):1135–1143CrossRefPubMed

30.

Peter N, Kleinjung T, Horat L, Schmidt-Weitmann S, Meyer M (2016) Validation of PRISM (Pictorial Representation of Illness and Self Measure) as a novel visual assessment tool for the burden of suffering in tinnitus patients. Health Qual Life Out 14:47CrossRef

31.

Wittmann L, Sensky T, Meder L, Michel B, Stoll T (2009) Suffering and posttraumatic growth in women with systemic lupus erythematosus (SLE): a qualitative/quantitative case study. Psychosomatics 50(4):362–374CrossRefPubMed

32.

Wilson K, Amir Z (2008) Cancer and disability benefits: a synthesis of qualitative findings on advice and support. Psycho-Oncol 17(5):421–429CrossRef

Title: Pictorial Representation of Illness and Self Measure-Revised 2 (PRISM-R2): an effective tool to assess perceived burden of thyroid cancer in mainland China
Authors: Yanbo Wang
Suyun Fan
Hongbiao Wang
Li Li
Yanyan Jia
Li Chai
Publication date: 01-09-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4172-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2018

‘Being with’ or ‘doing for’? How the role of an end-of-life volunteer befriender can impact patient wellbeing: interviews from a multiple qualitative case study (ELSA)

Development of esthetic prosthesis for a patient with severe stigmatizing facial lesions due to cancer: a pilot study

A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study

Perceptions of care and patient-reported outcomes in people living with neuroendocrine tumours

Heart rate variability for rapid risk stratification of emergency patients with malignant disease

Keynote webinar | Spotlight on antibody–drug conjugates in cancer